Open Collections

Trends in utilization of proton pump inhibitors in British Columbia

Therapeutics Initiative (University of British Columbia)

Therapeutics Letter 118 investigates trends in utilization of proton pump inhibitors in British Columbia, Canada. Conclusions PPI utilization in British Columbia has risen much faster than population growth. For most indications, PPIs are only recommended for up to 8 weeks duration. In many clinical settings, we do not know whether the benefits of long-term PPI use outweigh the harms. Patients on long-term PPI therapy should be reassessed.

British Columbia

Text

The UBC TI is funded by the BC Ministry of Health to provide evidence-based information about drug therapy. We neither formulate nor adjudicate provincial drug policies.

Vancouver : University of British Columbia Library

10.14288/1.0433697

Medicine, Faculty of; Anesthesiology, Pharmacology and Therapeutics, Department of

Faculty; Researcher

DSpace